EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
Recruiting · NCT06525298 · Registry updated 2024-09-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors | Advanced Solid Tumor; HRR Deficiency; Homologous Recombination Deficiency | Recruiting | Phase 1 / Phase 2 | 2024-09-19 | NCT06525298 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eisbach Bio GmbH | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| MD Anderson Cancer Center | Houston | United States | 589 |